IL-10 signaling in dendritic cells attenuates anti-Leishmania major immunity without affecting protective memory responses

Journal of Investigative Dermatology

Volumn 135, Issue 11, 2015, Pages 2890-2894

  Girard Madoux, Mathilde J H ^a   Kautz Neu, Kordula ^b   Lorenz, Beate ^b   Ober Blöbaum, Julia L ^b   Von Stebut, Esther ^b   Clausen, Björn E ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TRANSCRIPTION FACTOR FOXP3; IL10 PROTEIN, HUMAN;

AMASTIGOTE; CELL ACTIVATION; CELL DIVISION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; LEISHMANIA MAJOR; LETTER; MACROPHAGE; MEMORY; NEUROPROTECTION; NONHUMAN; PARASITE IMMUNITY; PARASITOSIS; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DISEASE MODEL; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MOUSE; PATHOGENICITY; PATHOPHYSIOLOGY; RANDOMIZATION; SKIN LEISHMANIASIS;

ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; RANDOM ALLOCATION; SIGNAL TRANSDUCTION;

EID: 84947017931     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.236     Document Type: Letter

References (15)

1. Anderson CF, Oukka M, Kuchroo VJ et al. (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285-97
2. Belkaid Y, Hoffmann KF, Mendez S et al. (2001) The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194:1497-506
3. Belkaid Y, Piccirillo CA, Mendez S et al. (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420:502-7
4. Clausen BE, Girard-Madoux MJ (2013) IL-10 control of dendritic cells in the skin. Oncoimmunology 2:e23186
5. Girard-Madoux MJ, Kel JM, Reizis B et al. (2012) IL-10 controls dendritic cell-induced T-cell reactivation in the skin to limit contact hypersensitivity. J Allergy Clin Immunol 129: 143-50
6. Groux H, Cottrez F, Rouleau M et al. (1999) A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J Immunol 162: 1723-9
7. Hagenbaugh A, Sharma S, Dubinett SM et al. (1997) Altered immune responses in interleukin 10 transgenic mice. J Exp Med 185: 2101-10
8. Kamanaka M, Kim ST, Wan YY et al. (2006) Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25: 941-52
9. Kautz-Neu K, Meyer RG, Clausen BE et al. (2010) Leishmaniasis, contact hypersensitivity and graft-versus-host disease: understanding the role of dendritic cell subsets in balancing skin immunity and tolerance. Exp Dermatol 19:760-71
10. Kautz-Neu K, Noordegraaf M, Dinges S et al. (2011) Langerhans cells are negative regulators of the anti-Leishmania response. J Exp Med 208: 885-91
11. Mattner F, Di Padova K, Alber G (1997) Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun 65: 4378-83
12. Moore KW, de Waal Malefyt R, Coffman RL et al. (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765
13. Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845-58
14. von Stebut E, Belkaid Y, Jakob T et al. (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188:1547-52
15. Woelbing F, Kostka SL, Moelle K et al. (2006) Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med 203: 177-88